- In 2023, 10,910 inpatient discharges and deaths were related to the malignant neoplasm of liver and intrahepatic bile ducts, commonly known as liver cancer, which accounted for 4.0% of hospitalisation due to all types of cancers.
Figure 1. Number of In-patient Discharges and Deaths due to Liver Cancer, 1993-2023
- Liver cancer has been the third leading cause of cancer death in Hong Kong for years. In 2023, 1,408 persons died from liver cancer, accounting for 9.5% of all cancer deaths. The crude death rates for male and female were 30.0 and 9.2 per 100,000 population of respective sex.
Figure 2. Number of Deaths and Crude Death Rate due to Liver Cancer, 1981-2023
- In the years between 1981 and 2023, there was a general decreasing trend in age-standardised death rate due to liver cancer. In general, the age-standardised death rate due to liver cancer was higher in male. The age-standardised death rate showed a decreasing trend in recent years.
Figure 3. Age-standardised Death Rate due to Liver Cancer, 1979-2023
- In general, the age-specific death rates of liver cancer for both sexes increased with age. In 2023, the age-specific death rates of male aged 35 and above were higher than those of female.
Figure 4. Age-specific Death Rate due to Liver Cancer, 2023
Note(s):
Classification of diseases and causes of death is based on the International Statistical Classification of Diseases and Related Health Problems (ICD) 10th Revision from 2001 onwards. Figures from 2001 onwards may not be comparable with figures for previous years which were compiled based on the ICD 9th Revision.
Liver cancer corresponds to codes 155 in ICD-9 and C22 in ICD-10.